- Email: [email protected]
Biotechnology—Impact on societal institutions
T&wIogj Ilr So&y, Vol. 4, p. 247 (1982) Printed in the USA. All tights-d.
0160-791X182 $3.00 + .OO Copyrighe 1983 Pmgamon Press Ltd
Biotechnology - Impact on Societal Institutions Introduction to the Special Series Beginning in this issue, Tech/ogy In Society will feature a timely and outstanding series of papers on “Biotechnology- Impact on Societal Institutions.” The editors of the Journal feel fortunate that Joseph G. Perpich, M.D., J.D., a distinguished executive in the field, has agreed to be Guest Editor of Technology In Society for this series. Dr. Perpich, Vice President for Governmental Affairs, Genex Corporation, is a psychiatrist and attorney. He graduated from the University of Minnesota Medical School in 1966, completed his internship at the University of Minnesota Hospitals and then his residency in psychiatry at the Massachusetts General Hospital and the National Institute of Mental Health. A mental health career development award from the National Institute of Mental Health allowed Dr. Perpich to combine his psychiatric and legal training with a year as a Congressional Fellow on the Senate Committee on Labor and Public Welfare’s Subcommittee on Health, and a year as a law clerk to David Bazelon, then Chief Judge for the US Court of Appeals for the District of Columbia Circuit. Dr. Perpich received his law degree from the Georgetown University Law Center in 1974. From 1974 to 1976, Dr. Perpich served at the Institute of Medicine, the National Academy of Sciences, where he was responsible for developing a program in legal and medical ethics. From 1976 to 1981 he held the post of Associate Director for Program Planning and Evaluation at the National Institutes of Health under NIH Director Donald S. Fredrickson. Dr. Perpich’s first assignment in that position was to direct the staff effort on developing the NIH recombinant DNA research guidelines and related Federal legislative, judicial and executive policies. Other responsibilities included the development of planning processes and Federal research strategies. During his last two years at the NIH, Dr. Perpich worked to bring industry further into the government-university partnership in health research - especially in biotechnology. Dr. Perpich is a fellow of the American Psychiatric Association and a member of the Bar of the District of Columbia.
247
0160-791X182 $3.00 + .OO Copyrighe 1983 Pmgamon Press Ltd
Biotechnology - Impact on Societal Institutions Introduction to the Special Series Beginning in this issue, Tech/ogy In Society will feature a timely and outstanding series of papers on “Biotechnology- Impact on Societal Institutions.” The editors of the Journal feel fortunate that Joseph G. Perpich, M.D., J.D., a distinguished executive in the field, has agreed to be Guest Editor of Technology In Society for this series. Dr. Perpich, Vice President for Governmental Affairs, Genex Corporation, is a psychiatrist and attorney. He graduated from the University of Minnesota Medical School in 1966, completed his internship at the University of Minnesota Hospitals and then his residency in psychiatry at the Massachusetts General Hospital and the National Institute of Mental Health. A mental health career development award from the National Institute of Mental Health allowed Dr. Perpich to combine his psychiatric and legal training with a year as a Congressional Fellow on the Senate Committee on Labor and Public Welfare’s Subcommittee on Health, and a year as a law clerk to David Bazelon, then Chief Judge for the US Court of Appeals for the District of Columbia Circuit. Dr. Perpich received his law degree from the Georgetown University Law Center in 1974. From 1974 to 1976, Dr. Perpich served at the Institute of Medicine, the National Academy of Sciences, where he was responsible for developing a program in legal and medical ethics. From 1976 to 1981 he held the post of Associate Director for Program Planning and Evaluation at the National Institutes of Health under NIH Director Donald S. Fredrickson. Dr. Perpich’s first assignment in that position was to direct the staff effort on developing the NIH recombinant DNA research guidelines and related Federal legislative, judicial and executive policies. Other responsibilities included the development of planning processes and Federal research strategies. During his last two years at the NIH, Dr. Perpich worked to bring industry further into the government-university partnership in health research - especially in biotechnology. Dr. Perpich is a fellow of the American Psychiatric Association and a member of the Bar of the District of Columbia.
247